Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Data Survey Report 2025
Summary
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
as follows:
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
- Novo Nordisk
- AstraZeneca
- Eli Lily
- GSK
- Sanofi
- Bristol-Myers Squibb
- Amylin
as follows:
- Hospital
- Pharmacy
- Others
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Novo Nordisk
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 AstraZeneca
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Eli Lily
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 GSK
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Sanofi
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Bristol-Myers Squibb
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Amylin
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Hospital
4.1.1 Overview
4.1.2 Hospital Market Size and Forecast
4.2 Pharmacy
4.2.1 Overview
4.2.2 Pharmacy Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Novo Nordisk
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 AstraZeneca
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Eli Lily
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 GSK
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Sanofi
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Bristol-Myers Squibb
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Amylin
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Hospital
4.1.1 Overview
4.1.2 Hospital Market Size and Forecast
4.2 Pharmacy
4.2.1 Overview
4.2.2 Pharmacy Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
LIST OF TABLES
Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lily
Tab Sales Revenue, Volume, Price, Cost and Margin of GSK
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of Amylin
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lily
Tab Sales Revenue, Volume, Price, Cost and Margin of GSK
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of Amylin
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
LIST OF FIGURES
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2011-2017 (Value)
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2011-2017 (Volume)
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Value)
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Volume)
Fig Hospital Market Size and CAGR 2011-2017 (Value)
Fig Hospital Market Size and CAGR 2011-2017 (Volume)
Fig Hospital Market Forecast and CAGR 2018-2025 (Value)
Fig Hospital Market Forecast and CAGR 2018-2025 (Volume)
Fig Pharmacy Market Size and CAGR 2011-2017 (Value)
Fig Pharmacy Market Size and CAGR 2011-2017 (Volume)
Fig Pharmacy Market Forecast and CAGR 2018-2025 (Value)
Fig Pharmacy Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2011-2017 (Value)
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2011-2017 (Volume)
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Value)
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Volume)
Fig Hospital Market Size and CAGR 2011-2017 (Value)
Fig Hospital Market Size and CAGR 2011-2017 (Volume)
Fig Hospital Market Forecast and CAGR 2018-2025 (Value)
Fig Hospital Market Forecast and CAGR 2018-2025 (Volume)
Fig Pharmacy Market Size and CAGR 2011-2017 (Value)
Fig Pharmacy Market Size and CAGR 2011-2017 (Volume)
Fig Pharmacy Market Forecast and CAGR 2018-2025 (Value)
Fig Pharmacy Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
